Genoptix Files For IPO

San Diego-based Genoptix said this afternoon in a filing with the SEC that it is looking to raise up to $86.25M in an IPO. The firm said that it is looking to list on the NASDAQ Global Market as "GXDX." The IPO is being underwritten by Lehman Brothers, Banc of America Securities, and Cowen and Company; the firm is venture backed by Enterprise Partners, Chicago Growth Partners, William Blair Capital Partners, Alliance Technology Ventures, Tullis-Dickerson, Excelsior Venture Partners, and others. Genoptix provides laboratory and diagnostic services to hematologists and oncologists. According to the firm's filing, it had net income of $1.3M on revenues of $10.65M for the three quarters ended March 31, 2007; for 2006, the firm lost $3.7M on revenues of $24.0M.